Sanofi names new leaders to Executive Committee
29 Mayo 2020 - 12:00AM
Sanofi names new leaders to Executive
Committee
- Natalie Bickford appointed Chief People Officer
- Arnaud Robert appointed Chief Digital Officer
- Julie Van Ongevalle appointed Head of Consumer Healthcare
- Thomas Triomphe appointed Head of Sanofi Pasteur
PARIS – May 29, 2020 - Sanofi
has named four new leaders to its Executive Committee. These
appointments now complete the announced changes in February to
further simplify the Company’s executive leadership team.
The complete Sanofi Executive Committee now
includes the four heads of the Company’s global business units
(Sanofi Genzyme, Sanofi Pasteur, General Medicines, and Consumer
Healthcare) as well as the global Heads of Research and
Development, Industrial Affairs, Finance, Human Resources, Legal
and Digital.
“My objective has been to find the right blend
of talented people that can make the whole team stronger than its
individual parts. Sanofi needs people who can bring us new insights
from the outside of the industry as well as people with world-class
pharma expertise. We need leaders who come to Sanofi with a fresh
perspective as well as leaders who have grown up within the
company,” says Paul Hudson, Chief Executive Officer at Sanofi. “I
am confident in this team’s capacity to inspire our people, execute
our strategy and change the practice of medicine for patients.”
Natalie Bickford, Executive Vice
President, Chief People Officer
Natalie Bickford starts on August 1, and joins
Sanofi from Merlin Entertainments, the world’s second largest
location-based entertainment business (which includes Legoland
Resorts, Madame Tussaud’s, SEALIFE aquariums, among other brands).
At Merlin, she was responsible for 30,000 employees across Europe,
North America, and Asia Pacific. Ms. Bickford brings a wealth of
consumer-facing experience. She held previous Human Resources
leadership positions at Sodexo, AstraZeneca, and Kingfisher, has
consistently demonstrated passion for engaging teams and driving
change in behaviors and culture. She also has a solid track record
of transforming organizations, with a strong focus on inclusion and
diversity.
Arnaud Robert, Executive Vice President,
Chief Digital Officer (CDO)
Arnaud Robert is currently Chief Digital Officer
at Viking Cruises, a cruise line provider. He joins as Sanofi’s CDO
on June 15, and will drive Sanofi’s digital, data and technology
strategy. As newcomer to the pharma sector, Robert brings a strong
background in consumer, omni-channel experience,
platform/technology, big data and front-end digital experience. He
has held previous leadership positions at The Walt Disney Company
and Nike, where he designed and launched the Apple Watch l Nike+
digital community.
Julie Van Ongevalle, Executive Vice
President, Head of Consumer Healthcare
Julie Van Ongevalle starts on September 1,
replacing Alan Main. She is currently Global Brand President of
Origins, a division of the Estée Lauder Companies, based in New
York City. With more than 20 years of international experience, Van
Ongevalle has built brands, from identifying accelerated growth
opportunities, to building and implementing execution plans
resulting in sustainable, long-term profitable growth. Her deep
knowledge of consumers and digital will be essential as Sanofi
advances builds a standalone, agile and multi-local brands Consumer
Healthcare business.
Thomas Triomphe, Executive Vice
President, Head of Sanofi Pasteur
Thomas Triomphe currently serves as Head of
Franchises and Product Strategy for Sanofi Pasteur, and will be
promoted to Executive Vice President, Head of Sanofi Pasteur,
effective June 15. Triomphe replaces David Loew. Triomphe
joined Sanofi Pasteur in 2004 as part of a talent management
program and has since held different roles of increasing
responsibility in sales and marketing, at the country, regional,
and global levels.
The Company extends sincere thanks to David Loew
and Alan Main for their leadership and outstanding contributions.
Most recently, both executives have played a critical role in
harnessing Sanofi’s efforts and resources in the fight against
COVID-19.
About Sanofi Sanofi is dedicated to
supporting people through their health challenges. We are a global
biopharmaceutical company focused on human health. We prevent
illness with vaccines, provide innovative treatments to fight pain
and ease suffering. We stand by the few who suffer from rare
diseases and the millions with long-term chronic
conditions. With more than 100,000 people in 100 countries,
Sanofi is transforming scientific innovation into healthcare
solutions around the globe. Sanofi, Empowering Life |
Sanofi
Media Relations Ashleigh KossTel: +1 (908)
981-8745ashleigh.koss@sanofi.com Quentin Vivant Tél.: +33 (0)1
53 77 46 46mr@sanofi.com |
Sanofi Investor Relations
Felix Lauscher Tel.: +33 (0)1 53 77 45 45 ir@Sanofi.com |
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024